Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1990873
PUBLISHER: GlobalData | PRODUCT CODE: 1990873
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Global Clinical Trials Review, 2026
PUBLISHED:
PAGES: 4673 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's clinical trial report, "Human Immunodeficiency Virus (HIV) Infections (AIDS) - Global Clinical Trials Review, 2026" provides an overview of Human Immunodeficiency Virus (HIV) Infections (AIDS) Clinical trials scenario. This report provides top line data relating to the clinical trials on Human Immunodeficiency Virus (HIV) Infections (AIDS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Product Code: GDHC7329CTIDB
Table of Contents
Table of Contents
List of Tables
List of Figures
- Report Guidance
- GlobalData Clinical Trials Report Coverage
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Five Countries Contributing to Clinical Trials in Middle East and Africa
- Top Five Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by G7 Countries: Proportion of Human Immunodeficiency Virus (HIV) Infections (AIDS) to Infectious Disease Clinical Trials
- Clinical Trials by Phase in G7 Countries
- Clinical Trials in G7 Countries by Trial Status
- Clinical Trials by E7 Countries: Proportion of Human Immunodeficiency Virus (HIV) Infections (AIDS) to Infectious Disease Clinical Trials
- Clinical Trials by Phase in E7 Countries
- Clinical Trials in E7 Countries by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Clinical Trials by End Point Status
- Subjects Recruited Over a Period of Time
- Clinical Trials by Sponsor Type
- Prominent Sponsors
- Top Companies Participating in Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials
- Prominent Drugs
- Latest Clinical Trials News on Human Immunodeficiency Virus (HIV) Infections (AIDS)
- Feb 23, 2026: HIV patients show lower steatotic liver disease with ViiV's Dovato vs Biktarvy
- Feb 18, 2026: Viiv's Long-Acting Cabenuva for HIV Demonstrates Efficacy Compared to Oral Therapy for People With Adherence Challenges; Results Published in NEJM
- Feb 09, 2026: First of Its Kind Daily HIV Treatment Shows Promising Results
- Jan 26, 2026: Immuno Cure Kicks off Phase I Clinical Study of Therapeutic DNA Vaccine for HIV in Hong Kong
- Dec 15, 2025: Gilead's HIV ART combo deemed non-inferior in second Phase III trial
- Clinical Trial Profile Snapshots
Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Source
Product Code: GDHC7329CTIDB
List of Table
List of Tables
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials by Region, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Europe, Top Five Countries, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, North America, Top Countries, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2026*
- Proportion of Human Immunodeficiency Virus (HIV) Infections (AIDS) to Infectious Disease Clinical Trials, G7 Countries (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
- Proportion of Human Immunodeficiency Virus (HIV) Infections (AIDS) to Infectious Disease Clinical Trials, E7 Countries (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials by Phase, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials In Progress by Phase 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials by Trial Status, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Global, by End Point Status, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*
List of Figure
List of Figures
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials by Region (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, North America, Top Countries (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2026*
- Proportion of Human Immunodeficiency Virus (HIV) Infections (AIDS) to Infectious Disease Clinical Trials, G7 Countries (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
- Proportion of Human Immunodeficiency Virus (HIV) Infections (AIDS) to Infectious Disease Clinical Trials, E7 Countries (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials by Phase (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials In Progress by Phase, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics, Global, Clinical Trials by Trial Status, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Global, by End Point Status, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
- Human Immunodeficiency Virus (HIV) Infections (AIDS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*
- GlobalData Methodology
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.